Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.2973
+0.0002 (0.07%)
Feb 19, 2026, 9:52 AM EST - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Injectable Biologics
9.29M
Injectable Biologics Growth
69.16%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
9.29M
United States Growth
69.16%